Oncimmune Holdings plc announced that further to the announcement made on 7 December 2022, John Goold has been appointed to the Board of the Company as Non-Executive Director with immediate effect, following the successful completion of customary due diligence checks by the Company's Nominated Adviser. Additional Information in respect of the AIM Rules: The following information regarding the appointment of John Howard Goold, aged 51, is disclosed under Schedule 2(g) of the AIM Rules for Companies.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.6 GBX | -5.98% | -7.45% | -6.35% |
May. 21 | EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss | AN |
May. 21 | Earnings Flash (ONC.L) ONCIMMUNE HOLDINGS Posts Fiscal H1 Revenue GBP1.2M | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.35% | 23.77M | |
+16.86% | 79.28B | |
+7.97% | 8.74B | |
-16.33% | 4.84B | |
+51.22% | 4.74B | |
+2.18% | 3.87B | |
+21.35% | 2.46B | |
-26.79% | 2.18B | |
+15.12% | 2.09B | |
-36.56% | 1.98B |
- Stock Market
- Equities
- ONC Stock
- News Oncimmune Holdings plc
- Oncimmune Holdings plc Announces Appointment of John Goold as Non-Executive Director